TAK-875

CAS : 1000413-72-8

Ref. TR-T004915

Informations sur le produit

• Nom: TAK-875
• Synonymes: (3S)-6-[[2',6'-Dimethyl-4'-[3-(methylsulfonyl)propoxy][1,1'-biphenyl]-3-yl]methoxy]-2,3-dihydro-3-benzofuranacetic Acid, Tak875, 3-Benzofuranacetic acid, 6-[[2',6'-dimethyl-4'-[3-(methylsulfonyl)propoxy][1,1'-biphenyl]-3-yl]methoxy]-2,3-dihydro-, (3S)-, Tak-875

Description

Applications TAK-876 is a selective G protein-coupled receptor 40 (GPR40) agonist (1,2). TAK-876 is a novel oral medication that has been developed to improve the secretion of insulin in a glucose-dependent manner, which has the potential to improve the control of blood sugar levels with a low risk of hypoglycemia.
References (1) Arak, T., et al.: Diabetes. Obesity. Metabolism., 14, 271 (2012) (2) Burant, C.F.,et al.: Lancet., 379, 1403 (2012)

• Marque: TRC

Propriétés chimiques

• Masse moléculaire: 524.6252
• Formule: C₂₉H₃₂O₇S
• Couleur/Forme: Off White Solid
• InChI: InChI=1S/C29H32O7S/c1-19-12-25(34-10-5-11-37(3,32)33)13-20(2)29(19)22-7-4-6-21(14-22)17-35-24-8-9-26-23(15-28(30)31)18-36-27(26)16-24/h4,6-9,12-14,16,23H,5,10-11,15,17-18H2,1-3H3,(H,30,31)/t23-/m1/s1
• Code InChI: InChIKey=BZCALJIHZVNMGJ-HSZRJFAPSA-N
• SMILES: Cc1cc(OCCCS(C)(=O)=O)cc(C)c1-c1cccc(COc2ccc3c(c2)OC[C@H]3CC(=O)O)c1